Vidushi Sinha, COO & Pankaj Sinha, CEO

Dr. Saudamini Sinha, Medical Advisor

India's pharmaceutical market is experiencing unprecedented growth, fueled by innovation, rising healthcare demands, and increased access. The industry, often termed a 'Green Belt' sector, has seen consistent expansion since the 19th century. Currently valued More Than ?222905cr (As per IQVIA) annually, the prescription market alone grows at over 8 percent annually. This growth is particularly evident in the chronic segment, addressing lifestyle diseases such as Diabetes, Hypertension, and Cardiovascular conditions. Patients with these chronic conditions often require lifelong medication, contributing to sustained demand and ensuring the industry's continued expansion and critical role in healthcare.

To this end, Minitoss Medicines has swiftly established itself in India’s competitive pharmaceutical market since its inception in September 2021. The company is committed to an ethical, prescription-based business model, ensuring sustainable advancement and excellence in healthcare solutions. Minitoss Medicines integrates its core values of integrity, responsibility, reliability, and honesty into daily operations through a customer-centric approach and strong relationships with healthcare professionals. The company distinguishes itself by offering high-quality, cost-effective products, catering to doctors' needs for affordability without compromising on product quality. This strategic alignment has enabled them to achieve a turnover of ?7.5 crore in just two and a half years, despite competition from industry giants.

Minitoss has also diversified into Ayurvedic and nutraceutical products, responding to increasing demand for alternative therapies. By offering long shelf lives and flexible pricing, the company taps into a lucrative market while incentivizing its workforce with performance-based rewards. This innovative strategy has positioned the company for continued growth and success.

Led by Vidushi Sinha ( COO-MiniToss Medicines, Pharmacist, YOGA Teacher & Evaluator YCB AYUSH certified). Pankaj Sinha (CEO- MiniToss Medicines, IIM-C Alumni, YOGA Therapist YCBLevel- 6 AYUSH Approved,YOGA Teacher & Evaluator, Diploma in Naturopathy & Yogic Science (DNYS). Dr Saudamini Sinha ( Medical Advisor, MiniToss Medicines, PHARM-D, Doctor of Pharmacy. YOGA Therapist YCB-Level-6 AYUSH Approved, YOGA Teacher & Evaluator). Dr. Saudamini Sinha, with her pharmaceutical doctorate, directs product development and strategic communication, while Vidushi Sinha, with two decades of pharmaceutical career experience drives product innovation and finance management. CEO Pankaj Sinha, bringing over 27 years of industry experience, an Alumni of IIM-Calcutta (SURGE PROGRAM) manages marketing, sales, and future growth, ensuring the company’s success in key market segments such as cardiology and diabetology through an ethical, prescriptionbased business model.

Synergy of Allopathic and Ayurvedic Solutions

Minitoss Medicines stands out from other pharmaceutical companies in India through its comprehensive product range and commitment to providing tailored solutions. In the fields of cardiology and diabetology, where dosage accuracy is critical, MiniToss offers a full spectrum of strengths—from starting a minimum dose to up to maximum doses—ensuring that patients receive the exact dosage without compromising the integrity of sustained-release, and other formulation properties. This meticulous attention to detail sets Minitoss apart from competitors who may fear product expiry due to extensive inventory.

Another unique aspect of Minitoss is its blend of allopathic and Ayurvedic products. The company addresses common health issues in India by offering Ayurvedic solutions that are safe for diabetics and children. Their innovative product line includes treatments for kidney stones, providing a non-surgical alternative for stones under 10mm, and a menstrual health product that supports women from menarche to menopause, Liver Tonic for fatty Liver all of which are Ayurvedic and highly effective.

Although a relatively new company, Minitoss Medicines leverages strategic partnerships with established WHO-GMPcertified manufacturers to ensure scientific advancement and high-quality production. The company collaborates with industry giants including Mascot, Salud, Bajaj Formulation, Cosmas , Zenon, Bajaj Ayurvedic, Instacure, Ratnaraj Healthcare, Akums Drugs among others to produce medications that meet stringent quality standards. As the company grows, plans are in place to further expand its in-house research and manufacturing capabilities.

'Customer satisfaction is at the core of Minitoss Medicines' operations. We consider not only doctors but also employees, Distributors and patients as key customers. With approximately zero employee attrition since its inception, we foster a motivated and appreciated workforce by providing timely incentives, promotions, and recognition. Doctors benefit from support in patient outreach through free health camps, scientific data sharing, and diagnostic equipment Training at subsidized costs . By organizing continuous learning programs with conducting conferences, we ensure doctors stay updated with the latest medical advancements, ultimately benefiting both healthcare professionals and patients', emphasizes Pankaj Sinha.

Envisioning Healthcare Innovation

Minitoss Medicines envisions its role as a key player in the pharmaceutical industry by combining innovation with a holistic approach to healthcare. Since its inception in September 2021, the company has focused on establishing a sustainable revenue model while navigating the competitive market. While Minitoss Medicines has made significant inroads in major cities and states such as Gujarat, Maharashtra, and Punjab, the next strategic move involves penetrating smaller towns and rural regions, poised to extend its services to tier B and C towns. Recognizing the growing need for specialized healthcare in smaller regions, the company plans to recruit and train a dedicated team to deliver affordable and accessible treatments.

In addition to allopathic medicines, the company is strengthening its Ayurvedic product line, addressing widespread health issues such as constipation, which often coexists with diabetes and cardiac problems. The company aims to provide scientifically-backed, 100% natural Ayurvedic solutions, catering to patients in underserved areas.

MiniToss Medicines is committed to integrating traditional Ayurvedic practices with modern allopathic treatments, leveraging the expertise of its certified AYUSH leadership expertise. This holistic approach seeks to offer comprehensive healthcare solutions, benefiting both patients and the company’s long-term growth. This integrated model not only aims to meet the diverse needs of patients but also positions MiniToss Medicines as a forward-thinking leader in the pharmaceutical industry.